| Medical and Health Sciences | 2021-2025 | 976 | IT 66 | 99.77 |
| Biological Sciences | 2021-2025 | 835 | IT 20 | 99.10 |
| Psychiatry and Mental health | Lifetime | 225 | IT 4 | 99.32 |
| Genetics | Lifetime | 635 | IT 8 | 98.46 |
| Pediatrics, Perinatology and Child Health | Lifetime | 594 | IT 9 | 98.18 |
| Rheumatology | Lifetime | 443 | IT 22 | 98.12 |
| Clinical Neurology | Lifetime | 900 | IT 33 | 94.27 |
| Clinical Biochemistry | Lifetime | 732 | IT 27 | 83.31 |
| Psychiatry and Mental health | 2021-2025 | 46 | IT 3 | 99.39 |
| Genetics | 2021-2025 | 156 | IT 6 | 95.79 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 236 | IT 8 | 95.39 |
| Molecular Biology | 2021-2025 | 801 | IT 18 | 95.59 |
| Rheumatology | 2021-2025 | 228 | IT 18 | 93.18 |
| Medical Physiology | 2021-2025 | 721 | IT 34 | 88.53 |
| Cellular and Molecular Neuroscience | 2021-2025 | 199 | IT 6 | 84.90 |
| Clinical Neurology | 2021-2025 | 435 | IT 33 | 84.75 |
| Clinical Biochemistry | 2021-2025 | 69 | IT 4 | 75.03 |
| Epilepsy research and treatment | Lifetime | 58 | IT 4 | 99.55 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 74 | IT 3 | 99.41 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 20 | IT 3 | 99.24 |
| Genetics and Neurodevelopmental Disorders | Lifetime | 116 | IT 2 | 99.22 |
| Genomics and Rare Diseases | Lifetime | 104 | IT 2 | 98.86 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 43 | IT 1 | 98.03 |
| Metabolism and Genetic Disorders | Lifetime | 692 | IT 33 | 97.95 |
| Genomic variations and chromosomal abnormalities | Lifetime | 395 | IT 11 | 97.33 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 671 | IT 61 | 97.40 |
| Fetal and Pediatric Neurological Disorders | Lifetime | 723 | IT 44 | 94.34 |
| Migraine and Headache Studies | Lifetime | 898 | IT 141 | 91.70 |
| Genetics and Neurodevelopmental Disorders | 2021-2025 | 4 | IT 2 | 99.66 |
| Epilepsy research and treatment | 2021-2025 | 14 | IT 4 | 99.63 |
| Glycogen Storage Diseases and Myoclonus | 2021-2025 | 2 | IT 1 | 99.32 |
| Neuroscience and Neuropharmacology Research | 2021-2025 | 23 | IT 4 | 99.07 |
| Pharmacological Effects and Toxicity Studies | 2021-2025 | 20 | IT 4 | 99.11 |
| Metabolism and Genetic Disorders | 2021-2025 | 64 | IT 11 | 96.00 |
| Genomics and Rare Diseases | 2021-2025 | 155 | IT 4 | 95.64 |
| Diet and metabolism studies | 2021-2025 | 459 | IT 35 | 95.52 |
| Ion channel regulation and function | 2021-2025 | 163 | IT 8 | 91.77 |
| Genomic variations and chromosomal abnormalities | 2021-2025 | 314 | IT 9 | 86.21 |
| Neuromodulation and Treatments for Neurological Disorders | 2021-2025 | 802 | IT 85 | 88.91 |
| Cellular transport and secretion | 2021-2025 | 415 | IT 11 | 81.79 |
| Ion Transport and Channel Regulation | 2021-2025 | 190 | IT 6 | 79.16 |
| Child and Adolescent Health | 2021-2025 | 758 | IT 7 | 72.56 |
| Amino Acid Enzymes and Metabolism | 2021-2025 | 388 | IT 41 | 72.07 |
| Lysosomal Storage Disorders Research | 2021-2025 | 894 | IT 117 | 72.96 |
| Neurofibromatosis and Schwannoma Cases | 2021-2025 | 809 | IT 60 | 71.29 |
| Fetal and Pediatric Neurological Disorders | 2021-2025 | 944 | IT 56 | 69.59 |
| Infant Health and Development | 2021-2025 | 638 | IT 53 | 62.80 |
| Ethics and Legal Issues in Pediatric Healthcare | 2021-2025 | 641 | IT 11 | 58.39 |
| Chromatin Remodeling and Cancer | 2021-2025 | 854 | IT 41 | 56.63 |
| Congenital Ear and Nasal Anomalies | 2021-2025 | 155 | IT 20 | 54.64 |
| Connexins and lens biology | 2021-2025 | 711 | IT 25 | 52.44 |
| Protein Tyrosine Phosphatases | 2021-2025 | 546 | IT 65 | 52.85 |
